KIDSORTHOPEDIATRICS CORP
Surgical & Medical Instruments & Apparatus
- Revenue
- $236M
- 15% YoY
- Operating margin
- -16.6%
- 2.9% YoY
- EBITDA
- −$18M
- 14% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$16M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear8% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear23% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $98M | $122M | $149M | $205M | $236M | 15% |
| Operating income | −$18M | −$25M | −$27M | −$35M | −$39M | 12% |
| Net income | −$16M | $1M | −$21M | −$38M | −$40M | 4.8% |
| Operating cash flow | −$13M | −$22M | −$27M | −$27M | −$5M | 82% |
| Capex | $8M | $10M | $17M | $14M | $11M | 22% |
| Stock-based comp | $6M | $7M | $11M | $14M | $18M | 31% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $21M · 6
- Net
- −$21M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 30 | 75000 |
| FY2024 | — | — | 56 | 75000 |
| FY2023 | — | — | 79 | 72000 |
| FY2022 | — | — | 96 | 75000 |
| FY2021 | — | — | 145 | 100000 |